annual D&A:
$1.23M+$348.00K(+39.68%)Summary
- As of today (September 15, 2025), TARS annual depreciation & amortization is $1.23 million, with the most recent change of +$348.00 thousand (+39.68%) on December 31, 2024.
- During the last 3 years, TARS annual D&A has risen by +$913.00 thousand (+292.63%).
- TARS annual D&A is now at all-time high.
Performance
TARS Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$453.00K-$7000.00(-1.52%)Summary
- As of today (September 15, 2025), TARS quarterly depreciation & amortization is $453.00 thousand, with the most recent change of -$7000.00 (-1.52%) on June 30, 2025.
- Over the past year, TARS quarterly D&A has increased by +$214.00 thousand (+89.54%).
- TARS quarterly D&A is now -1.52% below its all-time high of $460.00 thousand, reached on March 31, 2025.
Performance
TARS quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$1.63M+$214.00K(+15.12%)Summary
- As of today (September 15, 2025), TARS TTM depreciation & amortization is $1.63 million, with the most recent change of +$214.00 thousand (+15.12%) on June 30, 2025.
- Over the past year, TARS TTM D&A has increased by +$814.00 thousand (+99.88%).
- TARS TTM D&A is now at all-time high.
Performance
TARS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TARS Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.7% | +89.5% | +99.9% |
| 3 y3 years | +292.6% | +121.0% | +136.4% |
| 5 y5 years | +3210.8% | - | - |
TARS Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +292.6% | -1.5% | +819.0% | at high | +136.4% |
| 5 y | 5-year | at high | +3210.8% | -1.5% | +819.0% | at high | +1224.4% |
| alltime | all time | at high | >+9999.0% | -1.5% | +819.0% | at high | +5933.3% |
TARS Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $453.00K(-1.5%) | $1.63M(+15.1%) |
| Mar 2025 | - | $460.00K(+6.5%) | $1.42M(+15.5%) |
| Dec 2024 | $1.23M(+39.7%) | $432.00K(+52.1%) | $1.23M(+67.8%) |
| Sep 2024 | - | $284.00K(+18.8%) | $730.00K(-10.4%) |
| Jun 2024 | - | $239.00K(-11.5%) | $815.00K(-8.6%) |
| Mar 2024 | - | $270.00K(-528.6%) | $892.00K(+1.7%) |
| Dec 2023 | $877.00K(+169.0%) | -$63.00K(-117.1%) | $877.00K(-24.3%) |
| Sep 2023 | - | $369.00K(+16.8%) | $1.16M(+15.8%) |
| Jun 2023 | - | $316.00K(+23.9%) | $1.00M(+12.5%) |
| Mar 2023 | - | $255.00K(+16.4%) | $890.00K(+12.8%) |
| Dec 2022 | $326.00K | $219.00K(+3.8%) | $789.00K(+8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $211.00K(+2.9%) | $726.00K(+5.4%) |
| Jun 2022 | - | $205.00K(+33.1%) | $689.00K(+5.5%) |
| Mar 2022 | - | $154.00K(-1.3%) | $653.00K(+7.8%) |
| Dec 2021 | $312.00K(+225.0%) | $156.00K(-10.3%) | $606.00K(+11.0%) |
| Sep 2021 | - | $174.00K(+3.0%) | $546.00K(+46.8%) |
| Jun 2021 | - | $169.00K(+57.9%) | $372.00K(+83.3%) |
| Mar 2021 | - | $107.00K(+11.5%) | $203.00K(+65.0%) |
| Dec 2020 | $96.00K(+159.5%) | $96.00K(+255.6%) | $123.00K(+355.6%) |
| Mar 2020 | - | $27.00K | $27.00K |
| Dec 2019 | $37.00K(+3600.0%) | - | - |
| Dec 2018 | $1000.00 | - | - |
FAQ
- What is Tarsus Pharmaceuticals, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. annual D&A year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. quarterly D&A year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. TTM D&A year-on-year change?
What is Tarsus Pharmaceuticals, Inc. annual depreciation & amortization?
The current annual D&A of TARS is $1.23M
What is the all time high annual D&A for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high annual depreciation & amortization is $1.23M
What is Tarsus Pharmaceuticals, Inc. annual D&A year-on-year change?
Over the past year, TARS annual depreciation & amortization has changed by +$348.00K (+39.68%)
What is Tarsus Pharmaceuticals, Inc. quarterly depreciation & amortization?
The current quarterly D&A of TARS is $453.00K
What is the all time high quarterly D&A for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high quarterly depreciation & amortization is $460.00K
What is Tarsus Pharmaceuticals, Inc. quarterly D&A year-on-year change?
Over the past year, TARS quarterly depreciation & amortization has changed by +$214.00K (+89.54%)
What is Tarsus Pharmaceuticals, Inc. TTM depreciation & amortization?
The current TTM D&A of TARS is $1.63M
What is the all time high TTM D&A for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high TTM depreciation & amortization is $1.63M
What is Tarsus Pharmaceuticals, Inc. TTM D&A year-on-year change?
Over the past year, TARS TTM depreciation & amortization has changed by +$814.00K (+99.88%)